Stanford University
Showing 2,141-2,160 of 2,472 Results
-
Vidyani Suryadevara
Instructor, Genetics
Current Research and Scholarly InterestsA Bioengineer by training, she has a breadth of experiences across different scientific disciplines including pulmonary diseases, Alzheimer’s disease, and musculoskeletal disorders, wherein her research projects involved unraveling signaling mechanism behind the disease in order to identify new therapeutic targets and developing imaging modalities for early diagnosis of the disease, thus eventually improving the quality of life in patients. Her current work has been centered around age-associated pathophysiologies like osteoarthritis and Alzheimer's Disease. Her research currently focuses on the clinical translation of a novel noninvasive multimodality imaging approach to detect senescence in osteoarthritis and Alzheimer's Disease and understand the senescence biology in these age-associated diseases.
She has led teams of renowned senescence scientists across the US to develop expert recommendations for biomarkers for senescence. She is also a faculty fellow in the Center for Innovation at Global Health, wherein her focus is to develop region-specific lifestyle interventions to prevent dementia. -
Robert Sutton
Professor of Management Science & Engineering, Emeritus
BioRobert I. Sutton is an organizational psychologist and best-selling author. He studies leadership, innovation, organizational change, and workplace dynamics. Sutton has published over 200 articles, chapters, and case studies. His focus recently is scaling and leading at scale—how to grow organizations, spread good things (and remove bad things) in teams and organizations, and enhance performance, innovation, and well-being in big organizations.
Sutton received his PhD in Organizational Psychology from The University of Michigan and has served on the Stanford faculty since 1983. He served as Professor of Management Science & Engineering until 2023 and is now Professor Emeritus at Stanford. Sutton is co-founder and former co-director of the Center for Work, Technology and Organization, co-founder of the Stanford Technology Ventures Program, and co-founder of the “Stanford d.school.” Sutton was a resident Fellow at the Center for Advanced Study in the Behavioral Sciences during multiple years. He has served on the editorial boards of numerous scholarly publications and as an editor for Administrative Science Quarterly and Research in Organizational Behavior.
Sutton has served as an advisor to McKinsey & Company, Bain & Company, and Microsoft, a Fellow at IDEO, a board member of the Institute for the Future, a Senior Scientist at Gallup, and on faculty at the World Economic Forum in Davos. He is currently an advisor to Teamraderie and Asana’s Work Innovation Lab. Sutton is the academic co-director of Stanford executive education programs including Customer Focused Innovation and Innovation and Entrepreneurship. He has given more than 200 keynote speeches in more than 20 countries.
Sutton’s academic honors include the award for the best paper published in the Academy of Management Journal, induction into the Academy of Management Journals Hall of Fame, the Eugene L. Grant Award for Excellence in Teaching, the McGraw-Hill Innovation in Entrepreneurship Pedagogy Award, and the award for the best article published in the Academy of Management Review. The London Business School selected Sutton for the 2014 Sumantra Ghoshal Award “for rigour and relevance in the study of management.” The American Management Association selected Sutton as one of the top 30 leaders who most influenced business in 2014 (ranking him 10th).
Sutton’s eight books and two edited volumes include (with Jeffrey Pfeffer) The Knowing-Doing Gap, selected by Jack Covert and Todd Sattersten as one of the best 100 business books of all time, and Weird Ideas That Work, selected by the Harvard Business Review as one of the best ten business books of the year. Hard Facts, Dangerous Half-Truths, and Total Nonsense was selected by Toronto’s Globe and Mail as the top management book of 2006 and by Strategy+Business as one of the best 10 books in the last decade.
The No Asshole Rule—a New York Times (NYT), Wall Street Journal (WSJ), and Businessweek bestseller—was translated into over 20 languages and sold over 900,000 copies. Good Boss, Bad Boss is a NYT and WSJ bestseller. Scaling-Up Excellence (with Huggy Rao) is a WSJ bestseller that was selected as one of the best business books of the year by Amazon, Financial Times, Inc., and others. The Asshole Survival Guide was selected as book of the month by the Financial Times.
Sutton’s latest book (with Rao), The Friction Project, unpacks insights from their seven-year learning adventure using academic research, case studies, classes and workshops, and ongoing dialog with scholars, executives, and innovators to learn how smart organizations make the right things easier and the wrong things harder.
Sutton’s research and opinions have appeared in the press, including NYT, The Times (of London), Financial Times, Fortune, WSJ, Wired, Vanity Fair, Washington Post, and more. Sutton has been a guest on numerous radio and television shows and podcasts. Learn more at bobsutton.net -
Yuri Suzuki
Stanley G. Wojcicki Professor, Professor of Applied Physics, and by courtesy, of Materials Science and Engineering
Current Research and Scholarly InterestsHer interests are focused on novel ground states and functional properties in condensed matter systems synthesized via atomically precise thin film deposition techniques with a recent emphasis has been on highly correlated electronic systems:
• Emergent interfacial electronic & magnetic phenomena through complex oxide heteroepitaxy
• Low dimensional electron gas systems
• Spin current generation, propagation and control in complex oxide-based ferromagnets
• Multifunctional behavior in complex oxide thin films and heterostructures -
Katrin J Svensson
Associate Professor of Pathology
Current Research and Scholarly InterestsMolecular metabolism
Protein biochemistry
Cell biology and function
Animal physiology -
James Swartz
Emeritus Faculty, Academic Council, Chemical Engineering
Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances. -
Julie K. Sydor
HIT Fund Innovation Strategy Manager, Office of Technology Licensing (OTL)
Current Role at StanfordHIT Fund Innovation Strategy Manager
-
Karl G. Sylvester
Professor of Surgery (Pediatric Surgery)
Current Research and Scholarly InterestsScholarly interests include investigation of molecular markers of human disease that provide diagnostic function, serve as targets for possible therapeutic manipulation, or provide insight into mechanisms of human disease. Specific diseases of interest include common conditions of pregnancy, gut microbial ecology and Necrotizing Enterocolitis (NEC).
-
Daniel Sze, MD, PhD
Professor of Radiology (Interventional Radiology), Emeritus
Current Research and Scholarly InterestsTransarterial administration of chemotherapeutics, radioactive microspheres, and biologics for the treatment of unresectable tumors; management of portal hypertension and complications of cirrhosis (TIPS); treatment of complications of organ transplantation; Venous and pulmonary arterial thrombolysis and reconstruction; Stent and Stent-graft treatment of peripheral vascular diseases, aneurysms, aortic dissections
-
Christopher N. Ta, MD
Professor of Ophthalmology
BioChristopher N. Ta, MD specializes in the diagnosis and medical treatment of cornea diseases. His areas of expertise are in the treatment of ocular infections, inflammation, and ocular surface diseases. He has conducted numerous clinical trials toward the prevention and treatment of ocular infections. Dr. Ta also has extensive clinical experience in the treatment of ocular graft-versus host disease following hematopoietic stem cell transplantation.
-
Holly Tabor
Professor of Medicine (Primary Care & Population Health) and, by courtesy, of Pediatrics (Stanford Center of Biomedical Ethics) and of Epidemiology
Current Research and Scholarly InterestsMy research focuses on ethical issues in genetics and genomics, specifically return of results and translation for exome and whole genome sequencing and translation of genomic sequencing into the clinical setting. I also conduct research on ethical issues in clinical care and research for patients and families with autism and other developmental and cognitive disabilities.
-
William Talbot
Mary and Dr. Salim Shelby Professor
Current Research and Scholarly InterestsWe use genetic and cellular approaches to investigate the molecular basis of glial development and myelination in the zebrafish.
-
Longzhi Tan
Assistant Professor of Neurobiology
Current Research and Scholarly InterestsThe Tan Lab studies the single-cell 3D genome architectural basis of neurodevelopment and aging by developing the next generation of in vivo multi-omic assays and algorithms, and applying them to the human and mouse cerebellum.
